Description
PRIME TE 400 – Testosterone Enanthate 400mg/ml
PRIME TE 400 provides a high-concentration formulation of Testosterone Enanthate designed for experienced users who require optimized hormone replacement or performance support. This long-acting ester of testosterone offers a stable release profile, supporting consistent serum levels with less frequent administration.
Mechanism of Action:
Testosterone Enanthate acts as a primary androgen, binding to androgen receptors in muscle and other tissues to promote protein synthesis, nitrogen retention, red blood cell production, and recovery. It aromatizes to estradiol at a moderate rate, contributing to a balanced anabolic-to-androgenic effect.
Use Case:
Ideal for advanced performance cycles focused on strength enhancement, hypertrophy, or physiological hormone optimization. Commonly utilized as a base compound in multi-agent protocols due to its predictable action and wide compatibility with other esters and compounds.
Advantages of High-Concentration Format:
At 400mg/ml, this formula minimizes injection volume while maintaining pharmacological efficacy. Especially suited for users managing complex regimens or looking to reduce carrier oil load without compromising hormone levels or results.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.